21 May 2013
Keywords: axcan, gets, priority, review, photofrin, canada, pharma
Article | 19 July 2001
Axcan Pharma has received priority review for the supplemental NewDrug Application that it filed with the Therapeutic Products Directorate of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.